$50M sweet spot round size
Most of their 14 investments are in rounds between $31M and $100M
2015
CG Oncology raised $105M on August 2, 2023
Investors: Decheng Capital, Foresite Capital, Longitude Capital, TCG X, Avidity Partners, RA Capital Management, L.P. and Malin Corporation plc
CG Oncology raised $105M on August 2, 2023
Investors: Decheng Capital, Avidity Partners, TCG X, Foresite Capital, RA Capital Management, L.P., Longitude Capital and Malin Corporation plc
Poseida Therapeutics, Inc. raised $142M on April 22, 2019
Investors: PENTWATER CAPITAL MANAGEMENT LP, Aisling Capital, Longitude Capital, Vivo Capital, Rapha Capital Management, LLC, Perceptive Advisors and Malin Corporation plc
Poseida Therapeutics, Inc. raised $31M on April 3, 2018
Investors: Tavistock Group, Vivo Capital, Longitude Capital and Malin Corporation plc
Poseida Therapeutics, Inc. raised $11M on August 2, 2017
Investors: Malin Corporation plc
Xenex Disinfection Services raised $38M on February 24, 2017
Investors: Tectonic Ventures and Malin Corporation plc
Artizan Biosciences, Inc. raised undisclosed on February 6, 2017
Investors: Malin Corporation plc
Wren Therapeutics Ltd raised undisclosed on January 16, 2017
Investors: Malin Corporation plc
Kymab Ltd raised $100M on November 24, 2016
Investors: Wellcome Trust, Bill & Melinda Gates Foundation, Woodford Investment Management, ORI Capital Limited and Malin Corporation plc
Poseida Therapeutics, Inc. raised $23M on December 23, 2015
Investors: Malin Corporation plc
$56M
from 1 investors over 1 rounds
Malin Corporation plc raised $56M on March 1, 2015
Investors: National Treasury Management Agency